Tor-Bjarne Nymark A Hovland H Bjørnstad E W Nielsen
10.2147/vhrm.s2410
Vasc Health Risk Manag
2008;4(2):477-9.
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/18561524/
Attention Deficit Disorder with Hyperactivity / drug therapy Cardiomyopathy, Dilated / chemically induced Central Nervous System Stimulants / adverse effects Methylphenidate / adverse effects
Attention Deficit Disorder with Hyperactivity / drug therapy Cardiomyopathy, Dilated / chemically induced Central Nervous System Stimulants / adverse effects Methylphenidate / adverse effects Case Reports Adolescent Attention Deficit Disorder with Hyperactivity / complications Cardiomyopathy, Dilated / physiopathology Cardiomyopathy, Dilated / therapy Dobutamine / therapeutic use Humans Intra-Aortic Balloon Pumping Male Norepinephrine / therapeutic use Obesity / complications Stroke Volume Sympathomimetics / therapeutic use Treatment Outcome Central Nervous System Stimulants Sympathomimetics Methylphenidate Dobutamine Norepinephrine
PMC2496981
18561524
A young man with acute dilated cardiomyopathy associated with methylphenidate
2008